Quinazoline Compounds And Their Use In Therapy
US-2015057263-A1 · Feb 26, 2015 · US
US11001559B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11001559-B2 |
| Application number | US-201716325022-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 15, 2017 |
| Priority date | Aug 15, 2016 |
| Publication date | May 11, 2021 |
| Grant date | May 11, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to 4-substituted isoquinoline compounds and their derivatives and uses thereof for treatment of cancer, for example, acute myeloid leukemia.
Opening claim text (preview).
What is claimed is: 1. A compound represented by a formula of HSN608: or a pharmaceutically acceptable salt, N-oxide, hydrate, solvate, tautomer or optical isomer thereof. 2. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt, N-oxide, hydrate, solvate, tautomer, or optical isomer thereof, and a pharmaceutically acceptable carrier or diluent.
with hetero atoms directly attached in positions 2 and 4 · CPC title
Nitrogen atom · CPC title
linked by a carbon chain containing aromatic rings · CPC title
Nitrogen atoms · CPC title
Spiro-condensed systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.